TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presentado sáb, 29 ago · 09:00 CESTHot Line 2Todos los ensayos Hot Line →

REACT

2026

DETECTion of the Prevalence of Silent Atherosclerosis Across Adult Life and Development of a Risk Calculator to Predict Its Presence — Phase I of the REACT (Early Cure of Atherosclerosis) Project

In 16,808 adults aged 18–70 years without known cardiovascular disease, whole-body imaging for atherosclerosis was studied for the age- and sex-specific prevalence of silent atherosclerosis.

Resultado

Variable principal: Prevalence of silent atherosclerosis, defined as atherosclerotic plaque in at least one examined territory (carotid, femoral or coronary), at the baseline imaging visit

Silent atherosclerosis in 57.1% of participants overall: about 1 in 13 aged 18-29 and 9 of 10 aged 60-70. Men were affected 5-10 years earlier than women, who showed a steep rise around menopause. SCORE2 classified only a small minority of those with plaque as high risk, and almost none of the young.

Publicación original
Subtema
Subclinical atherosclerosis
Diseño
Prospective multicenter observational cohort in Denmark and Spain, adults 18-70 years without known ASCVD enrolled in five prespecified age strata balanced for sex and country; cross-sectional baseline multimodality imaging (3D vascular ultrasound of carotid and femoral arteries, coronary CT angiography, non-contrast CT calcium); study follow-up to 2032
Relevancia
Importante: uno de varios pilares.
Fuente
Bundgaard H, Ibanez B, et al. N Engl J Med. 2026; published online 29 August.doi 10.1056/nejmoa2609059

Discusión y crítica

A prevalence map, not a treatment trial: multimodality imaging of 16,808 adults shows plaque long before any risk score calls the person high risk. The gap between 57% with disease and the handful SCORE2 flags is the finding, and it cuts both ways: it may mean the score misses people, or that plaque at 25 is common enough to be near-normal. Nothing here shows that imaging these people and treating what is found prevents an event; the cohort runs to 2032, and that is the study that will answer it.